FIELD: medicine; pharmaceutics.
SUBSTANCE: invention refers to pharmacology and medicine, namely to use of 7-hydroxycoumarin derivative of general formula (I), having protonophore activity. R in formula (I) is a linear alkyl containing 6–15 carbon atoms.
EFFECT: stimulation of selective degradation of mitochondria in cells (mitophagy) by means of 7-hydroxycoumarin derivative of general formula (I).
3 cl, 5 dwg
Title | Year | Author | Number |
---|---|---|---|
MILD CATIONIC MITOCHONDRIAL UNCOUPLERS | 2010 |
|
RU2527519C2 |
SUBSTITUTED CYANOPYRROLIDINES HAVING ACTIVITY OF USP30 INHIBITORS | 2020 |
|
RU2822680C1 |
METHOD FOR STIMULATING MITOPHAGY AND AUTOPHAGY IN CELLS, METHOD FOR STIMULATING AUTOPHAGY OR MITOPHAGY FOR TREATING A CONDITION ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION | 2020 |
|
RU2765414C1 |
VANILIN DERIVATIVES WITH ANTITUMOUR ACTIVITY | 2016 |
|
RU2624903C1 |
BROMINE-CONTAINING STERICALLY HINDERED PHENOLS WITH ANTICANCER ACTIVITY | 2023 |
|
RU2822270C1 |
1-PROPYL-2-OXO-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID DIETHYLAMINOETHYLAMIDE HYDROCHLORIDE SHOWING ANESTHETIC, ANTIARRHYTHMIC, ANTIOXIDANT, ANTIMICROBIAL AND FUNGICIDAL ACTIVITY | 1990 |
|
RU1774624C |
PYRIDOXINE DERIVATIVES WITH NONLINEAR OPTICAL PROPERTIES | 2012 |
|
RU2501801C1 |
COMBINATION OF SIROSINGOPIN AND MITOCHONDRIAL INHIBITORS FOR TREATMENT OF CANCER AND FOR IMMUNOSUPPRESSION | 2012 |
|
RU2602937C2 |
THERAPEUTIC DRUG FOR DISEASES RELATED TO ENDOPLASMIC RETICULUM CELL DEATH IN CORNEAL ENDOTHELIUM | 2014 |
|
RU2712967C2 |
PHARMACEUTICAL COMPOSITION, CONTAINING INDOLE COMPOUND | 2010 |
|
RU2557243C2 |
Authors
Dates
2024-05-21—Published
2022-12-31—Filed